Joseph Guido - Invuity Insider

IVTY -- USA Stock  

USD 7.35  0.025  0.34%

Mr. Joseph Guido is Vice President of Business Development of the Company, since February 2016. From 2012 to 2016, Mr. Guido served as Senior Vice President of Marketing and Business Development for Hansen Medical, a publiclytraded robotics company in the vascular and cardiac sectors. Prior to joining Hansen Medical, Mr. Guido served as the President of Heartstitch Medical, a medical devices company, in 2011. Prior to joining Heartstitch Medical, Mr. Guido held a variety of leadership roles in Marketing, Sales and Business Development for both public and private medical device companies such as Stryker Endoscopy, Intuitive Surgical, Novare Surgical and Abbott Vascular Devices
Age: 49  President Since 2016  MBA    
Guido received his B.S. degree in business administration from Villanova University and his M.B.A. from Pepperdine University.

Management Efficiency

The company has return on total asset (ROA) of (39.66) % which means that it has lost $39.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (481.4) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.66 M in liabilities. Invuity has Current Ratio of 2.09 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Robert MitchellEndologix
Said BolorforoshHaemonetics Corporation
Meredith HuetterEndologix
Nabil ShabshabBecton Dickinson and Company
Stephen WetherupCantel Medical Corp
David WilsonHaemonetics Corporation
Sean MartinBaxter International
John SaronBovie Medical Corporation
Seth YellinCantel Medical Corp
Patrick StephensEndologix
Peter CliffordCantel Medical Corp
Daniel McBrideThe Cooper Companies
Marcus SchabackerBaxter International
Giuseppe AccogliBaxter International
Charles LoveEndologix
Patrick KaltenbachBecton Dickinson and Company
Scott PleauBaxter International
Eric NodiffCantel Medical Corp
William TozziBecton Dickinson and Company
Shari OQuinnEndologix
Todd AbrahamEndologix

Entity Summary

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and traded on BATS Exchange. It employs 161 people.Invuity (IVTY) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 161 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.

Invuity Leadership Team

Robert Gerberich, Vice President - Sales and Marketing
Douglas Heigel, VP of Operations
Daniel Wolterman, Director
Alex Vayser, Co-Founder and CTO
William Burke, Independent Director
Philip Sawyer, CEO and President and Director
Eric Roberts, Independent Director
Andrew Sale, Senior Vice President of Global Sales
Scott Flora, Director
Gregory Brown,
James Mackaness, CFO
Steve Annen, Vice President of Product Management and Strategy
Joseph Guido, Vice President of Business Development
Randall Lipps, Independent Director
Paul Davison, VP of RandD
Reza Zadno, Independent Director
Brett Robertson, Chief Business Officer, General Counsel
Gregory Lucier, Chairman of the Board
Marcia Fish, Chief Human Resource Officer

Stock Performance Indicators

Did you try this?

Run Money Flow Index Now


Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Money Flow Index

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.